AVEO Pharmaceuticals (AVEO) Plans Stock Offering
Tweet Send to a FriendGet Alerts AVEO Hot Sheet
Up)
Trade AVEO Now!
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by AVEO.
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The proposed size of the offering was note disclosed.
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
- VIVUS (VVUS) Prices $220M Convertible Debt Offering
- Klarman Baupost Gets Into Citi (C) Warrants, DIRECTV (DTV) and Elan (ELN); Cuts News Corp (NWSA)
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, RBC Capital, Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
